The Spectrum of Still's Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 Patients

• Published in: Journal of clinical medicine 2022-11, Vol.11 (22), p.6703
• Main Authors: Neau, Pierre-Antoine, El-Jammal, Thomas, Javaux, Clément, Fournier, Nicolas, Chol, Orlane, Adelaïde, Léopold, Ly, Kim Heang, Gerfaud-Valentin, Mathieu, Perard, Laurent, Fouillet-Desjonqueres, Marine, Le Scanff, Julie, Vignot, Emmanuelle, Hot, Arnaud, Belot, Alexandre, Durieu, Isabelle, Sève, Pascal, Jamilloux, Yvan
• Format: Article
• Language: English
• Subjects: Arthritis; Biopsy; Bone marrow; Classification; Disease; Generalized linear models; Immunology; Life Sciences; Lymphatic system; Multivariate analysis; Patients; Remission (Medicine); Rheumatology; Variables
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11226703

Still's disease (SD) is a heterogeneous autoinflammatory disorder for which several phenotypes have been described. We conducted a retrospective study to re-evaluate the dichotomous view of the disease, to compare the juvenile and adult forms, and to look for prognostic factors. We collected data from ten French centers, seeking patients with a diagnosis of adult-onset SD (AOSD) or systemic juvenile idiopathic arthritis (sJIA). We identified 238 patients, 152 (64%) of whom had AOSD while 86 (36%) had sJIA. The median age at SD onset was 26.6 years. In patients with identifiable patterns, the course of SD was systemic in 159 patients (74%), chronic in 55 (26%). Sore throat and myalgia were more frequent in patients with AOSD. Abnormal liver tests, serum ferritin and C-reactive protein levels were higher in AOSD group. Fever and skin rash were predictive of complete remission or recovery and high lactate dehydrogenase level was a poor prognosis factor. Symptoms such as splenomegaly, skin rash, high polymorphonuclear neutrophils count and macrophage activation syndrome were predictive of a systemic phenotype. Overall, there were no major differences between sJIA and AOSD. Our results are consistent with the "biphasic" model of an autoinflammatory disease that can progress to chronic arthritis if not treated early.